COVOVAX Clinical Trials Begins in India: ICMR Partners With Serum Institute of India For Conducting Phase 2/3 Bridging Clinical Trial Of COVID-19 Vaccine
ICMR has partnered with Serum Institute to conduct phase 2/3 bridging clinical trial of COVOVAX.
ICMR has partnered with Serum Institute to conduct phase 2/3 bridging clinical trial of COVOVAX.
ICMR has partnered with @SerumInstIndia to conduct phase 2/3 bridging clinical trial of #COVOVAX. First three volunteers have been recruited today under the ICMR-SII NOVAVAX bridging study led by @IcmrNari at Nobel Hospital, Pune. @MoHFW_INDIA @DeptHealthRes @PIB_India pic.twitter.com/qxVf3dXJxz
— ICMR (@ICMRDELHI) March 25, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Mar 28, 2021 09:20 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
